H.B. Fuller Stock: Pricing Power vs Volume Decline

Higher prices are often treated as evidence of pricing power. If a company can charge customers more and still grow revenue, the argument seems straightforward: customers must value the product enough to absorb the increase.

That interpretation can be correct, but it skips an important step. Revenue can rise because prices increased even while customers buy less. In that situation, the company may still be protecting its economics successfully, but the evidence for durable pricing power is more complicated.

H.B. Fuller (FUL) provided a useful example in its latest quarter. The adhesives company reported higher revenue, stronger margins and higher earnings. Underneath those headline improvements, however, price and volume moved in opposite directions.

H.B. Fuller's growth came from price, not volume

H.B. Fuller reported third-quarter fiscal 2026 revenue of $938 million, up 5.2% year over year. Organic revenue increased 4.4%, which at first glance suggests a healthy underlying sales improvement.

The composition matters. Pricing added 7.4% to revenue, while volume declined 3.0%. Foreign exchange contributed another 0.7%, with acquisitions adding only 0.1%.

In other words, the business sold less volume but generated more revenue because the price contribution was large enough to offset that decline.

That is not automatically negative. Price and volume frequently move differently, particularly when input costs change quickly. But an investor trying to understand business quality should avoid treating 4.4% organic growth as though customers simply bought 4.4% more adhesives.

Why the price increases happened matters

Pricing power is usually most valuable when it reflects something structural about the relationship between a business and its customers. A differentiated product, high switching costs or an unusually important role in a customer's process can sometimes allow a company to raise prices without materially damaging demand.

H.B. Fuller's recent pricing actions also have a more immediate explanation. In March, the company announced a global price adjustment of at least 10% across its product lines, with larger increases in some technologies and regions. Management linked those increases to petrochemical constraints, raw-material availability and higher input costs.

That distinction matters. Passing an external cost shock through to customers can demonstrate commercial strength, but it is not quite the same evidence as raising prices because the underlying product has become more valuable or because customers have few realistic alternatives.

The strongest evidence develops through what happens next. Do customers stay? Does volume stabilize? Do margins improve after the higher input costs are absorbed? And can the company retain the increase once supply conditions normalize?

The margin result is more encouraging than the revenue number alone

H.B. Fuller's third-quarter margin development suggests the pricing actions are doing meaningful economic work. Adjusted gross margin increased to 33.5%, up 120 basis points year over year. Adjusted EBITDA increased 9% to $187 million, while adjusted EBITDA margin reached a record 19.9%, up from 19.1% a year earlier.

Management said pricing execution and restructuring savings drove most of the gross-margin improvement, while pricing was also the principal driver of the increase in adjusted EBITDA. Adjusted diluted EPS rose 21% to $1.52.

This is more informative than revenue growth alone. If a company raises prices merely to compensate for equivalent increases in its own costs, revenue can rise without producing much improvement in profitability. H.B. Fuller is currently showing margin expansion as well, suggesting that pricing and restructuring are improving the economics rather than simply making the income statement larger.

Still, there is an important difference between successful cost recovery and durable pricing power. One quarter of higher margins does not settle that question.

Volume decline should not be ignored

The 3.0% decline in quarterly volume deserves attention because it represents the other side of the pricing equation. Some volume weakness may reflect end-market demand rather than customer resistance to H.B. Fuller's price increases. Cyclical industrial businesses rarely provide a clean laboratory where price elasticity can be isolated from the broader economy.

That is one reason investors should follow the trend rather than draw too much from one quarter. H.B. Fuller's full-year outlook still assumes pricing up by a mid-single-digit percentage and volume down by a low-single-digit percentage. The price-volume divergence is therefore not confined to one reporting period.

If volumes eventually stabilize while prices and margins remain higher, the evidence for pricing strength becomes more convincing. If volume continues to deteriorate as pricing remains elevated, investors need to determine how much of that weakness reflects the economic cycle and how much reflects customers changing their behavior.

The distinction matters because revenue growth produced by more units sold has different implications from revenue growth produced almost entirely by price.

Cash and working capital add another layer

The income statement is not the only place to look. H.B. Fuller's net working capital reached 18.5% of annualized revenue in the third quarter, compared with 17.0% a year earlier. Management attributed much of the increase to strategic inventory investments intended to support its Quantum Leap program and protect supply continuity amid disruption in the Middle East.

Year-to-date operating cash flow was $183 million, up 17%. That is constructive, but the longer-term MOATEY evidence remains less comfortable. Following the latest update, MOATEY's five-year free-cash-flow growth measure moved from -5.32% to -20.94%.

At the same time, MOATEY's earnings-growth measure increased from 2.44% to 3.38%, revenue growth increased from 2.52% to 2.65%, and the total Growth assessment improved slightly from 1.4 to 1.6 points.

These figures are MOATEY framework measures and may include adjustments used in the company's evaluation. They should not automatically be treated as identical to the unadjusted figures reported by H.B. Fuller.

The disagreement between improving quarterly profitability and weak longer-term cash-flow evidence is exactly why fundamental analysis works better when several dimensions are considered together. A strong quarter can be genuine without erasing a weaker multi-year record.

What MOATEY currently sees

MOATEY currently classifies H.B. Fuller as a Cyclical and rates the company Poor, with an overall score of 22.6. Financial Health is the strongest part of the current assessment at 15 of 15 points. Growth receives 1.6 of 15, Management 2 of 15 and Moat 4 of 20.

Valuation currently contributes zero of 30 available points. The framework also identifies one major risk and three minor risks, including the cyclical nature of the business, historical shareholder dilution, long-term debt relative to free cash flow and limited evidence of a clear competitive advantage.

Those assessments do not negate the improvement reported this quarter. They simply place it in a longer-term context. H.B. Fuller can execute well on pricing and restructuring while other parts of the investment case remain less compelling.

How investors can test pricing power

The first test is whether price increases survive. Temporary increases imposed during raw-material shortages are economically different from pricing that remains in place once the shortage disappears. Investors should therefore watch whether H.B. Fuller retains pricing as supply conditions normalize.

The second is volume. True pricing power does not require volumes to rise every quarter, particularly in a cyclical industry, but persistent customer losses after repeated price increases would weaken the argument that demand is relatively insensitive to price.

The third is margin retention. If prices remain higher and gross margins continue improving, the company is keeping more of the economic benefit. If margins fall back once cost pressures change, much of the recent pricing may have been simple cost recovery.

Finally, cash flow should eventually confirm the earnings improvement. Restructuring, inventory investment and acquisitions can make that relationship noisy in the short term, but over longer periods a stronger business should ultimately convert more of its economics into cash.

Higher prices are evidence, not the conclusion

H.B. Fuller's latest quarter contains several genuinely positive developments. Revenue increased, margins expanded, adjusted EBITDA reached a record margin and earnings improved. Management's pricing actions appear to be offsetting raw-material pressure while restructuring contributes additional efficiency.

At the same time, volume declined 3%, and the company still expects lower volume for the full year. That makes the quarter more interesting than a simple story about pricing power.

For investors, the useful distinction is between raising prices and possessing durable pricing power. The first can happen because costs increased. The second becomes clearer only when customers remain, margins hold and cash economics improve over time.

H.B. Fuller has demonstrated that it can raise prices. The next part of the analysis is whether those prices can coexist with stronger volumes and stronger long-term economics.